Research Reports

Healthcare

icon
Home » Reports » Cancer Services Market Global Demand Analysis Growth Opportunity Outlook 2023
Market Research Report

Cancer Services Market : Global Demand Analysis, Growth & Opportunity Outlook 2023

Published On : 04:45 AM, 31st October, 2017 REP-ID-227 Category: Healthcare

Global Cancer Services Market Overview

Cancer is distortion in which abnormal growth of cells form group of diseases. Cancer such as tumors spreads throughout the body and may results in organ failure. Unwanted or abnormal growth of several cells in the body contributes for the dysfunction character of the organ.

The cancer services market is estimated to expand in terms of demand in near future owing to increasing number of cancer patients across the globe. Growing awareness across the globe towards the early diagnosis for cancer in order to prevent the abnormal growth of cells is driving the market of cancer services. Rapid growth in healthcare sectors owing to increasing investments in research and development aims to provide affordable and effective cancer services for prevention, treatment and post treatment. Emerging economies are adopting advanced therapies and healthcare treatments to minimize the burden of cancer which will further help the federal authorities to minimize the healthcare spending. Moreover, introduction of favorable re-imbursement policies by the government organizations across the globe are likely to emphasize patients to adopt cancer services in near future.

                                 Cancer Services Market Demand

Market size and forecast

Under global cancer services market, the cancer therapy segment is projected to expand at a CAGR of 17.2% over the forecast period i.e. 2016-2023. Moreover, the breast cancer therapy segment accounted USD 25.5 Billion in 2015, expanding at a CAGR of 14.2% during the forecast period i.e. 2016-2023.

Regionally, North America accounted the highest market share in terms of revenue in overall market of cancer services across the globe. The market of North America region is expected to continue its dominance over the forecast period i.e. 2016-2023 on the back of introduction of favorable re-imbursement policies in the region, increasing incidences of cancer and adoption of technological advanced equipment for cancer diagnostics and advanced therapies for treatment of cancer. Moreover, the North-America market of cancer services is majorly driven on account of increasing personal disposable income of the population and increasing healthcare spending of population. The cancer patients in U.S. are increasing with pace and is expected to increase by 25% of the last year diagnosed patients i.e. 14.5 Million.

On the other hand, Asia-Pacific is expected to be the fastest growing and revenue generated market across the globe in near future. The market is driven by rising incidences of cancer patients and increasing awareness towards treatment and cure of cancer in Asia-pacific regions such as Japan, India, China, etc. Increasing investment in healthcare sector in order to reduce the burden of diseases in terms of human suffering is likely to grow the market of cancer services. The market of cancer services is riding on the back of governmental initiatives in the Asia-Pacific region which are creating awareness among the population regarding cancer services. However, major vaccine manufacturers are shifting towards India to increase profitability by participating in the India vaccine technology market is fostering the market of cancer services across the region.

Technological advancements in imaging sector and digitalization cancer diagnostics tests will shift the technology to a cutting-edge level of diagnosis. Characteristics such as time savings and precise diagnosis are some of the key elements for the growth of cancer services market.  Apart from this, automation of diagnostic test reduces time and cost and caters precise outputs, thus gaining trust of physicians and consumers across the globe.

Likewise, increasing awareness towards vaccinations and cancer therapeutics is increasing the demand for cancer services for prevention of life-threatening diseases. Rapid growth in geriatric population along with higher risk of cancer is shifting towards early diagnosis and preventive care services of cancer.

Market Segmentation

Our in-depth analysis segmented the global cancer services market in the following segments:

By Services

  • By Preventive Care Services
    • By Vaccines
      • Live Attenuated Vaccines 
      • Conjugate Vaccines
      • Inactivated Vaccines
      • Recombinant Vector Vaccines
      • Toxoid Vaccines 
      • Synthetic Vaccines
      • Dendritic Cell Vaccines
    • By Cancer Growth Blockers
      • Tyrosine kinase inhibitors
      • Proteasome inhibitors
      • mTOR inhibitors
  • By Diagnostic Care Services
    • By Diagnostic Tests
      • Prostate-specific antigen (PSA) Tests
      • Circulating Tumor Cells (CTC) Tests
      • Alpha-fetoprotein (AFP) Tests
      • Estimated Glomerular Filtration Rate (EGFR)
      • Other Diagnostic Tests
    •  By Imaging
      • MRI Scan
      • PET Scan
      • CT Scan
      • Mammography
      • Ultrasound
    • By Endoscopy
      • Bronchoscopy
      • Colonoscopy
      • Colposcopy
      • Others
    • By Biopsy
      • Bone Marrow Biopsy
      • Needle Biopsy
      • Endoscopic Biopsy
  • By Treatment Care Services
    • Hormone Therapy
    • Chemotherapy
    • Immunotherapy

By Application

  • Blood Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate Cancer

By End-User

  • Hospitals
  • Diagnostic Clinics
  • Specialty Cancer Hospitals

By Region

Global Cancer Services Market is further classified on the basis of region as follows:

  • North America (United States /U.S. & Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Western and Eastern Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Western Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia)
  • Middle East and North Africa (MENA)
  • Rest of World

Growth Drivers and challenges

The global market of cancer services is driven on the back of factors such as increase in aging population, growing awareness towards indications of cancers, shifting of patients towards cancer services for better treatment and early adoption of healthcare treatments. Additionally, increasing gross disposable income of the population which allows them to spend more on healthcare is expected to spur the demand for cancer services in near future.

Moreover, factors such as rising incidences of cancer across the globe, adoption of cancer services by the patients and increasing cases of early diagnosis in order to prevent cancer are expected to boost the market of cancer services during the forecast period i.e. 2016-2023. Likewise, government initiatives are creating awareness towards the treatment and prevention from cancer diseases. These long term initiative and increasing funding for healthcare researches are fostering the market of cancer services.

Advancement in technology in healthcare sector is helping the cancer patients to get effective and better treatment for cancer diseases. Continuous researches on cancer drugs and introduction of new and effective cancer treatment therapies are likely to foster the demand for cancer therapies globally over the forecast period i.e. 2016-2023.

Although, high cost of treatment, lack of awareness in under-developed nations, and lack of skilled healthcare physicians are some of the factors likely to hamper the market growth of cancer services market across the globe. Conversely, dearth of medical equipment and cancer treatment therapies in various undeveloped regions across the globe are hampering the growth of cancer services market. Manufacturers of cancer drugs, diagnostic equipment and various cancer treatment therapies are facing challenges in clinical trials on account of huge capital cost for research and development. Thus, high cost investment to develop effective and affordable cancer services are restraining the market of cancer services globally.

Key Players

The key players of cancer services market are as follows:

  • GE Healthcare
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials
  • Siemens Healthineers
  • Philips Healthcare
  • Abbott Diagnostics
  • Eli Lilly and Company
  • Novartis
  • Hoffman La-Roche Ltd.
  • Hitachi Medical Corporation
  • Hologic Inc.
  • Samsung Medison Co., Ltd. 
  • Shimadzu Corporation
  • Fonar Corporation 

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Cancer Services Market is segmented as follows:

  • By Preventive Care Services type Market Size and Y-O-Y Growth Analysis
  • By Diagnostics Care Services type Market Size and Y-O-Y Growth Analysis
  • By Treatment Care Services type Market Size and Y-O-Y Growth Analysis
  • By Basic Care Services type Market Size and Y-O-Y Growth Analysis
  • By End-user type Market Size and Y-O-Y Growth Analysis

By Regions

  • North America (U.S., Canada) Market Size and Y-O-Y Growth Analysis
  • Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
  • Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
  • Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
  • Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

 

                  Key Answers Captured in Report?

Which geography would have better demand for product/services?
What are the strategies adopted by big players in the regional market?
Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
What is the current & expected market size in next five years?
What is the market feasibility for long term investment?
What opportunity the country would offer for existing and new players in the market?
What is risk involved for suppliers in the geography?
What factors would drive the demand for the product/service in near future?
What is the impact analysis of various factors in the market growth?
What are the recent trends in the regional market and how successful they are?

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
Phone : +91 958 228 3827, +91 120 660 5495
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2017 Research Nester. All rights reserved

Top